Medivolve (MEDVF) Stock Price

Medivolve Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Medivolve has contracted by 59.8% per year over the past 3 years to 686,500.00 CAD. For Medivolve, the net margin of -2,427.9% is down versus -357.0% a few years ago.

Medivolve stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medivolve business model & stock analysis

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The firm has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

Frequently asked questions about Medivolve

Converted at the current exchange rate, the Medivolve share trades at 0.00 EUR (0.00 CAD).

The Medivolve share (MEDVF) is listed on 3 stock exchanges, including: Frankfurt (4NCA.F).

The revenue cannot currently be calculated for Medivolve.

The profit cannot currently be calculated for Medivolve.

The P/E ratio cannot be calculated for Medivolve at the moment.

The P/S cannot be calculated for Medivolve currently.

The Eulerpool Quality Score for Medivolve is 4/10.

The ISIN of Medivolve is CA58503M4083. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medivolve is A3D2J4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medivolve is MEDVF. The ticker symbol is used to trade Medivolve shares on the stock exchange.

Fair ValueTerminal
0.00 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Nov 16, 2009
ISIN
CA58503M4083
Cusip
58503M408
Market capitalization
3,814.63 CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
118.28 %
Last updated Nov 12, 2026, 12:48 AM

Medivolve Peer Group

Medivolve Ticker

FRANKFURT · 4NCA.FNEO · MEDV.NEOTC · MEDVF

Medivolve FIGI

MEDV:CN · BBG000Q84K68MEDV:TR · BBG000Q84MJ0MEDV:TX · BBG000Q84NR9MEDV:TG · BBG000Q84P304NCA:GR · BBG000RPSXJ1MEDVF:US · BBG000VXQNK1MEDVF:UV · BBG000VXQT004NCA:GF · BBG002KC3QX94NCA:GM · BBG002KC3R12MEDV:DT · BBG004JB8ZG3MEDV:DG · BBG005XRJKL4MEDV:QF · BBG0086KGVL2

All fundamentals and in-depth analysis of Medivolve

Our stock analysis for Medivolve stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medivolve. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.